rebetol solution

SVR for Peg-Intron plus Rebetol combination therapy is 41% for genotype 1, and 82% for genotypes 2 through 6. Peg-Intron is a reconstituted powder that is dosed according to a person's weight. Roche’s Pegasys plus Copegus: SVR for Pegasys plus Copegus combination therapy is 44-51% for genotype 1, and 70-82% for genotypes 2 through 6. Pegasys is a ready-made solution that is dosed at 180µg regardless of a person's weight.

That said you need to check out your Rebetol dose. Something is strange with your dosing. Generally, 800 mg Rebetol is the lowest dose given, while 150 mcg PegIntron is the highest. May I ask how much you weigh? Are you genotype 1? An easy way to look at if you are getting the correct weight based doses is to do these calculations: 1. Calculate your weight in kilos (your weight in lbs divided by 2.2). 2. Divide your ribavarin dose by your weight in kilos.

Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL).

Between copegus and rebetol which one is more effective for the treatment? Because copegus make me so weak. I prefer rebetol if they have the same effectiveness for the virus treatment.

In a 28-week treatment regimen in which patients received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID), the rate of sustained virological response at 12 weeks after the end of treatment (SVR 12) was 57 percent (ITT).

s not really going to advance your solution to your immediate heath problems if you focus on the connection with your treatment five years ago. Maybe it was but what difference does that make to fixing the problem today? What will advance a solution is to find a supportive and smart doctor, maybe an internist, who shows you respect and works hard to solve your health problems.

(1) In a 48-week boceprevir regimen, the SVR rate was 74 percent at 12 weeks after the end of treatment (SVR 12) in patients who received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID) (P/R lead-in). In a 28-week boceprevir regimen, the SVR rate was 56 percent at 24 weeks after the end of treatment (SVR 24) in patients who received the P/R lead-in.

Pivotal Study in Previously Untreated (Naive) Patients The primary objective of this pivotal study, known as HCV SPRINT-2 (HCV Serine Protease Inhibitor Therapy-2), is to evaluate the efficacy of 28- and 48-week regimens of boceprevir (800 mg TID) in combination with PEGINTRON (1.5 mcg/kg/week) and REBETOL (600-1400 mg/day) compared to a control of PEGINTRON and REBETOL alone for 48 weeks in previously untreated (naive) adult patients with chronic HCV genotype 1.

06 that just completed a 60 week treatment of Peg-intron and Rebetol. I was undetected at 12 weeks and stayed undetected through out the treatment. Unfortunately, the virus was detected 6 weeks after I stopped the treatment. I would really appreciate your thoughts on what you think would be the best course of action at this point. Any insight would be greatly appreciated!

Lola, I'm so sorry to know of your relapse. I can only imagine how hard this is on you to get to this point in treatment and get this sort of news. I think Jim gives you good advice, as usual. I hope things work out for you as you continue to investigate your options. I do have a question...I'm wondering if your Rebetol was weight-based and what your daily dosage was, if you don't mind me asking?

• PegIntron + REBETOL for four weeks followed by VICTRELIS 800 mg three times daily + PegIntron + REBETOL for 24 weeks. The subjects were then continued on different regimens based on Treatment Week (TW) 8 through TW24 response-guided therapy (VICTRELIS-RGT). All subjects in this treatment arm were limited to 24 weeks of therapy with VICTRELIS.

Your doctor has created his own hybrid by using Merck's Victrelis but replacing Merck's rebetol/pegintron and their dosing recommendations with the correct dosing for pegasys/copegus if it was used with Incivek. Personally although this is off the beaten path I don't see a problem with it because many people experience less side effects with pegasys but the efficacy is similar.

VICTRELIS-treated subjects who demonstrated interferon responsiveness at TW4 achieved SVR rates of 81% (203/252) in VICTRELIS-RGT arm and 79% (200/254) in VICTRELIS-PR48 arm, compared to 52% (134/260) in subjects treated with PegIntron/REBETOL.

not sure there is much of a difference but i have heard pegasys has less side effects.

My treatment nurse set me up on the program with Pegassist (Genentech Pegasys system): 1-888-941-3331 Peginterferon and Ribaviron Commitment to Care (Merck PEG-Intron system): 1-866-363-6379, opt 1 Hope that helps.

Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL). http://www.fda.

after taking pegintron with rebetol capsules,some skin minor damage has occured.i took the treathment for six months as my doctor requires me.i know that these medicines in combination has some bad side effects.can someone explain how i have some damage in skin and i scrach these most time,i dont feel to scrach these only when i put some cream on these small rounded patches .

I finished tx in december 2007 was undetected since week 12 of treatment relapsed 3 weeks after finishing 48 weeks of pegintron and rebetol. Will see my doc on march 31 will be doing treatment again. Some clear unfortunatly aloy relapse and that was very hard for me to accept because tx was very hard on me and my hopes were up that I had beaten it. Oh well I wish you better luck.

The bottle of REBETOL (ribavirin) Capsules should be stored at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Good luck with you treatment.. Will VICTRELIS capsules may also be stored at room temperature up to 77°F (25°C) for 3 months. • Keep VICTRELIS in a tightly closed container and away from heat http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_mg.

My Rebetol(ribavirin) are 200mg capsules. Not sure what you were prescribed. I take the Rebetol twice a day. I'm also on PegIntron Alfa2b, had hoped for the RediPens but they were not available, so I'm on the "mix & stick". I was told 4 weeks lead-in, then 24 weeks of triple with Victrelis. I may have misunderstood, but that's what I'm prepared for as of now. Day 11 for me, Wishing you all the best!

So this is probably where your dosage comes from, although it says that 800 mg ribavirin (Rebetol) is enough for your weight. I would be reluctant though to take less than 1.5 mcg PegIntron per kilo, but that is me. I would just take the full shot, I don't like being underarmed in this war. Here is the link: http://www.spfiles.com/pipeg-intron.

(841 kcal, 53.8 g fat, 31.6 g protein, and 57.4 g carbohydrate) in a single-dose pharmacokinetic study.

Rebetol solution

Common Questions and Answers about Rebetol solution

rebetol